# Phio Pharmaceuticals Corp.: Form 8-K, filed Jan 10, 2017

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2017-01-10
- Accepted by EDGAR: Jan 10, 2017, 17:21 ET
- Period: 2017-01-05
- Accession: 0001193125-17-006979
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000119312517006979/d286088d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000119312517006979/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.01: Delisting notice
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000119312517006979/d286088d8k.htm

Filed Jan 10, 2017.
Source: SEC EDGAR, the filing index for accession 0001193125-17-006979. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
